cancer cell proliferation, migration and invasion. CCDC34 may serve as a biomarker or even a therapeutic target for bladder cancer.
Background:
To compare the efficacy and safety of transurethral PlasmaKinetic enucleation of prostate (PKEP) versus transurethral PlasmaKinetic resection of prostate (PKRP) for benign prostate hyperplasia. Methods: The Prospective and randomized controlled trials (RCTs) pertaining to PKEP and PKRP for benign prostate hyperplasia were retrieved from PubMed, Wanfang and so on. The level of trials was assessed by using Cochrane system. Results: Compared with PKRP, the time of operation shorten 10.17 min, the time of catheterization and hospital stay shorten 22.30 h, 1.33 d respectively. The volume of intraoperative bleeding decreased 47.34 mL. The quantity of resectable prostate increase 10.76 g, difference is statistically significant (P<0.05). Compared with PKRP, the international prostate symptom score (IPSS) was lower after 3 months, the quality of life (QOL) and residual urine volume (RUV) was lower after 6 months, the maximum floe rate (Q max ) was higher after 3 and 6 months, difference is statistically significant (P<0.05). No significant differences were found in IPSS, QOL, Q max , RUV, international index of erectile function 5 (IIEF-5) between PKRP and PKEP after 1 and 2 years. The incidence of transfusion and capsular perforation was lower than PKRP, but the incidence of postoperative Transient urinary incontinence was higher than PKRP. Conclusions: Compared with PKRP, PKEP cause less blood loss and requires a shorter operation time, a shorter catheterization time and a shorter hospital stay. It resects the proliferated prostate more cleanly with lower incidence of capsular perforation, but the incidence of postoperative transient urinary incontinence was higher. The short-term efficacy of PKEP was better than PKRP, but no significant differences were found in long-term efficacy and the postoperation influence of sex function between PKEP and PKRP. 
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Zhongcheng Xin
Andrology Center, Peking University First Hospital, Peking University, Beijing 100034, China Abstract: In the last decade, the convergence of life sciences, physical sciences, and engineering has brought a host of opportunities and innovations for biomedical informatics and health care in microenergy medicine, and it is called the third revolution in the field of life science research. Low-energy shock wave therapy (LESWT), a form of physical therapy in energy medicine, was shown to markedly improve erectile function in patients with organic ED, as well as in diabetic rats. In addition, LESWT has been demonstrated to facilitate elongation of myelinated axons, with consequent neurologic functional recovery in a rat model. Low-intensity pulsed ultrasound (LIPUS) is a form of ultrasound that delivered at a much lower intensity than traditional ultrasound energy and output in the mode of pulse wave. LIPUS have been demonstrated to have a rage of biological effects on tissues, including promoting bone-fracture healing, accelerating softtissue regeneration, inhibiting inflammatory responses and so on. Recent studies showed that biological effects of LIPUS in healing morbid body tissues may be mainly associated with the upregulation of cell proliferation and promoting multilineage differentiation of mesenchyme stem/progenitor cell lines. Therapeutic magnetic field, a good paradigm of convergence medicine, has been demonstrated to have beneficial results in benign prostatic hyperplasia (BPH), human breast carcinoma, peripheral nerve regeneration, hand osteoarthritis, osteonecrosis, and nucleic acid delivery. Magnetic field has been proven to be a safe, non-invasive method for numerous cell and tissue modifications, especially in musculoskeletal system. Background: In the present study, we evaluated the safety and efficacy of immediate surgical bipolar PlasmaKinetic transurethral resection of the prostate (PK-TURP) for patients with benign prostatic hyperplasia (BPH) with acute urinary retention (AUR). Methods: We conducted a retrospective analysis of clinical data of BPH patients who received PK-TURP. A total of 1,126 BPH patients were divided #I# AUR (n=348) and non-AUR groups (n=778). Results: After the urethral catheters were removed, the urine white blood cell (WBC) count in the AUR group significantly increased compared with the non-AUR group (P<0.01). However, there was no significant difference in international prostate symptom score, painful urination, and maximal urinary flow rate. The duration of hospitalization of the AUR group was longer than that of the non-AUR group (P<0.001). A total of 87.1% (303/348) patients in the AUR group and 84.1% (654/778) patients in the non-AUR group completed all of the postoperative follow-up visits. The incidence of urinary tract infection in the AUR group within 3 months after surgery was significantly higher than that in the non-AUR group (P<0.01). The incidence of temporary urinary incontinence in the AUR group did not exhibit significant difference. During 3-12 months after surgery, there were no significant differences in major complications between the two groups. Multivariate regression analyses showed that age, postvoid residual, maximal urinary flow rate, diabetes, and hypertension, but not the presence of AUR, were independent predictors of IPSS post-K-URP. Conclusions: In conclusion, immediate PK-URP surgery on patients accompanied by AUR was safe and effective.
